What is the pathophysiology of Post-Infectious Glomerulonephritis (inflammation of the glomeruli following an infection) in children and young adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathophysiology of Post-Infectious Glomerulonephritis

Immune Complex-Mediated Mechanism

Post-infectious glomerulonephritis (PIGN) is fundamentally an immune complex-mediated disease where streptococcal antigens trigger immune complex deposition in glomerular tissue, causing inflammation and kidney damage. 1

The pathophysiologic cascade involves several key steps:

Streptococcal Antigens and Immune Activation

  • Nephritis-associated plasmin receptor (NAPlr), identified as glyceraldehyde-3-phosphate dehydrogenase, is one of the two leading streptococcal antigens involved in the pathogenesis. 2
  • Streptococcal pyrogenic exotoxin B (SPeB), a cationic cysteine proteinase, is the second major antigen implicated in triggering the immune response. 2, 3
  • Both NAPlr and SPeB have a high affinity for plasmin and glomerular proteins, which facilitates their deposition in the glomerulus. 3

Complement Activation and Glomerular Injury

  • The immune complexes activate the complement system primarily via the alternative pathway, though the lectin pathway also contributes. 2, 4
  • This complement activation is critical for generating inflammation by the immune complexes deposited in the glomerulus. 2
  • The result is low serum C3 complement levels, which is a hallmark laboratory finding in PIGN. 3

Temporal Relationship to Infection

  • The disease typically occurs 1-3 weeks after streptococcal pharyngitis or 4-6 weeks after impetigo, representing a latency period during which the immune response develops. 1
  • This delayed presentation distinguishes PIGN from direct infectious injury and confirms its immune-mediated nature. 1

Histopathologic Changes

  • The glomeruli are diffusely affected, presenting with enlarged glomerular tufts due to hypercellularity. 2
  • Proliferative endothelial and mesangial cells along with inflammatory cell infiltration are characteristic findings. 2
  • The inflammation results in the classic features of acute nephritic syndrome, including hematuria with red blood cell casts, proteinuria, hypertension, edema, and oliguria. 1, 4

Clinical Pitfalls

  • The pathogenesis is not fully understood despite recent advances, and ongoing research continues to identify additional antigens and mechanisms. 2
  • While group A β-hemolytic streptococcus (Streptococcus pyogenes) is the classic trigger, non-streptococcal organisms are emerging as main etiological agents in high-income countries, particularly staphylococcal infections in adults. 3
  • The immune response can occasionally lead to severe complications including rapidly progressive glomerulonephritis with crescent formation, though this is uncommon. 4, 5

References

Guideline

Management of Post-Streptococcal Glomerulonephritis (PSGN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Post-infectious glomerulonephritis.

Paediatrics and international child health, 2017

Research

Acute post-streptococcal glomerulonephritis in children - treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025

Related Questions

What are the key aspects of immune system formation in children, immunocomplexes, type III hypersensitivity reactions, and treatment of post-streptococcal glomerulonephritis (GNPE) and nephritic syndrome?
What is the appropriate management for a child presenting with symptoms suggestive of acute kidney injury, possibly due to post-streptococcal glomerulonephritis (PSGN), with impaired renal function, hypertension, and fluid overload?
What is the management of post-streptococcal (post-streptococcal infection) glomerulonephritis (inflammation of the glomeruli in the kidneys)?
What is the pathophysiology of glomerulonephritis following a streptococcal (strep) infection?
What is the management of acute glomerulonephritis in children?
Why does the sleep academic community not recommend trazodone (an antidepressant medication) as a first-line treatment for insomnia, particularly in elderly patients with a history of dementia or falls?
Is there a laboratory test to determine progression or improvement of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in a patient?
At what age is the first dose of Tetanus, diphtheria, and pertussis (Tdap) vaccine typically administered to infants?
What is the management for patients with return of spontaneous circulation (ROSC) after cardiac arrest who remain comatose?
What are the guidelines for using Azithromycin (a broad-spectrum antibiotic) in a patient with unknown medical history and demographics?
What is the elimination process of Bevacizumab (Avastin) (anti-vascular endothelial growth factor)

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.